Search

Displaying results 6991 - 7000 of 9886 in total
  1. Drug

    HH-009

    go.drugbank.com/drugs/DB18727
    Investigational

    HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment of hepatocellular carcinoma.

  2. Drug

    Calpurbatug

    go.drugbank.com/drugs/DB18734
    Investigational

    Calpurbatug (TRL1068) is a high-affinity and broad-spectrum human antibody that targets and disintegrates bacterial biofilm.

  3. Drug

    APL-030

    go.drugbank.com/drugs/DB18735
    Experimental

    APL-030 is a orally-active small molecule inhibitor of GCN2.

  4. Drug

    Celastrol

    go.drugbank.com/drugs/DB18736
    Experimental

    Celastrol is a pentacyclic triterpenoid isolated from the root extracts of _Tripterygium wilfordii_.[L50567]

  5. Drug

    Tetradecylthioacetic acid

    go.drugbank.com/drugs/DB18802
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Rocatinlimab

    go.drugbank.com/drugs/DB18809
    Investigational

    In clinical trials, it has shown significant efficacy and safety compared to a placebo. … Rocatinlimab is a subcutaneously administered anti-OX40 antibody developed for the treatment of moderate-to-severe atopic dermatitis.

  7. Drug

    ABG-023

    go.drugbank.com/drugs/DB18829
    Experimental

    ABG-023 is a glucagon analog which is soluble and solution-stable.[L50778]

  8. Drug

    Ziltivekimab

    go.drugbank.com/drugs/DB18836
    Investigational

    Ziltivekimab is under investigation in clinical trial NCT06200207 (A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation).

  9. Drug

    Depemokimab

    go.drugbank.com/drugs/DB18846
    ApprovedInvestigational

    Depemokimab is a humanized Immunoglobulin G1 (IgG1) monoclonal antibody and a long-acting drug. … [A275338] Depemokimab blocks interleukin-5 (IL-5), a key cytokine that regulates eosinophil maturation, survival, and recruitment.

  10. Drug

    Rosnilimab

    go.drugbank.com/drugs/DB18851
    Investigational

    Rosnilimab is under investigation in clinical trial NCT06041269 (A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)).